Whether you accept it, avoid it or live somewhere in between, insurance coverage has become a defining issue for our profession. Patients increasingly expect to use their benefits, practitioners want to be compensated fairly for their time and expertise, and the system itself remains – at best – fragmented. The encouraging news is that coverage has expanded in meaningful ways. The challenging news is that reimbursement, across the board, remains inadequate.
FDA Publishes New Guide on Supplement Labeling
The Food and Drug Administration's Office of Nutritional Products, Labeling and Dietary Supplements has posted a series of new guidelines on its Web site. Titled A Dietary Supplement Labeling Guide, the guidelines cover a variety of topics related to dietary supplements, including listing and placement of ingredients, health claims, and other issues, and are designed to present the agency's "current thinking" on the labeling of dietary supplements.

"This guidance document appears to be a very thorough review of the federal regulations that need to be considered when labeling a dietary supplement product," said Michael McGuffin, the president of the American Herbal Products Association. "This new guidance should be especially useful to companies that are new to the trade, but will also provide a helpful review for established firms."
The labeling guide is divided into eight chapters and six appendices, with the text in each chapter presented in a question-and-answer format. Topics of discussion include:
- General dietary supplement labeling
- Statement of identity
- Net quantity of contents
- Nutrition labeling
- Ingredient labeling
- Claims
- Premarket notification of new dietary ingredients
- Other labeling information
A Dietary Supplement Labeling Guide is currently available online at www.cfsan.fda.gov/~dms/dslg-toc.html.